Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002314574 | SCV000848342 | likely benign | Inborn genetic diseases | 2016-11-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000863231 | SCV001003857 | benign | Developmental and epileptic encephalopathy, 36 | 2024-01-05 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000863231 | SCV002524909 | benign | Developmental and epileptic encephalopathy, 36 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000863231 | SCV002807816 | likely benign | Developmental and epileptic encephalopathy, 36 | 2021-12-21 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003432753 | SCV004167453 | likely benign | not provided | 2023-03-01 | criteria provided, single submitter | clinical testing | ALG13: BP4, BS2 |